Hepatoid adenocarcinoma of the stomach: Thirteen case reports and review of literature

Table 3 Postoperative and follow-up data of 13 patients with hepatoid adenocarcinoma of the stomach

Serial number	TNM	Clinicopathologic stage	Lymph node	AFP	Hepatocyte	Adjuvant chemotherapy	Follow-up	Progression	Progression-free survival (mo)
1	T4aN3aM0	IIIB	(8/13)	+	-	Yes	Survival	No	56
2	T4aN2M0	IIIA	(5/15)	+	+	Yes	Death	Yes	28
3	T2N0M0	IB	(0/35)	-	+	Yes	Survival	No	56
4	T4N0M0	IIB	(0/14)	+	Unknown	Yes	Death	Yes	27
5	T4N1M0	IIIB	(6/22)	+	+	Yes	Lost	No	Unknown
6	T4N0M0	IIB	(0/18)	-	+	Yes	Survival	Yes	56
7	T4N3bM1	IV	(18/27)	+	+	Yes	Death	Yes	32
8	T4aN3aM0	IIIB	(7/18)	+	Unknown	No	Death	Yes	6
9	T4N3bM0	IIIC	(15/18)	-	+	Yes	Survival	Yes	23
10	T4bN2M0	IIIB	(7/23)	+	+	No	Death	Yes	1
11	T4bN1M0	IIIB	(3/17)	-	Unknown	Yes	Lost	Unknown	Unknown
12	T3N1M0	IIB	(3/21)	+	Unknown	No	Lost	Unknown	Unknown
13	T3N3bM0	IIIC	(16/19)	+	+	Yes	Survival	Yes	11

+ means positive; – means negative; AFP: Alpha-fetoprotein.